β- Nicotinamide- 1, N⁶- ethenoadenine dinucleotide ( ε-NAD⁺ / 1,N6-etheno-NAD+ ), sodium salt
P¹- (5'- [1, N⁶- Ethenoadenosyl])- P⁴- (5'- uridyl)- tetraphosphate ( ε-Ap₄U / ε-AppppU / ε-Up₄A)
P¹- (5'- [1, N⁶- Ethenoadenosyl])- P⁴- (5'- [1, N⁶- ethenoadenosyl])- tetraphosphate ( ε-Ap₄-ε-A / ε-Apppp-ε-A ), sodium salt
1, N⁶- Ethenoadenosine- 5'- O- monophosphate ( ε-5'-AMP / 1,N6-Etheno-AMP ), sodium salt
2'- O- (N'- Methylanthraniloyl)uridine- 3', 5'- cyclic monophosphate, sodium salt ( MANT-cUMP )
2'- / 3'- O- (N'- Methylanthraniloyl)uridine- 5'- O- monophosphate ( MANT-5'-UMP ), sodium salt
2'- / 3'- O- (N'- Methylanthraniloyl)cytidine- 5'- O- monophosphate ( MANT-5'-CMP ), sodium salt
Cyclic (guanosine- (2' −> 5')- monophosphate- 1, N⁶- ethenoadenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-ε-A(3',5')p] / ε-cGAMP(2'-5') / ε-2'3'-cGAMP / ε-2',5'-3',5'-cGAMP ), sodium salt
Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- O- (6- [sulfo-cyanine5]aminohexylcarbamoyl)adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-[sCya5]-AHC-A(3',5')p] ), sodium salt
Cyclic (guanosine- (2' −> 5')- monophosphate- 2'- O- (6- [DY-547P1]- aminohexylcarbamoyl)adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')p-2'-[DY-547P1]-AHC-A(3',5')p] ), sodium salt